Lupin launches generic Ancobon capsules in US

05 Jan 2018 Evaluate

Lupin has launched Flucytosine capsules USP, 250 mg and 500 mg, having received an approval from the United States Food and Drug Administration (USFDA), which are AB rated generic equivalent of Valeant Pharmaceuticals International Inc’s ANCOBON Capsules, 250 mg and 500 mg, indicated for the treatment of serious infections caused by susceptible strains of Candida and/or Cryptococcus.

Flucytosine Capsules USP, 250 mg and 500 mg had annual sales of approximately $48 million in the US, as per IMS MAT October 2017.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2097.65 5.70 (0.27%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×